A Lung Ultrasound-Based Nomogram for the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Hospitalized Children
Gangtie Liu,Guanglei Wang,Zhan Yang,Guangfu Liu,Haijun Ma,Yong Lv,Feiyan Ma,Weiwei Zhu
DOI: https://doi.org/10.2147/IDR.S387890
2022-11-01
Infection and Drug Resistance
Abstract:Gangtie Liu, 1, 2 Guanglei Wang, 2 Zhan Yang, 2 Guangfu Liu, 3 Haijun Ma, 3 Yong Lv, 2 Feiyan Ma, 2 Weiwei Zhu 1 1 Department of Pediatrics, Jinan Central Hospital, Shandong University, Jinan, People's Republic of China; 2 Department of Pediatrics, Taian Maternity and Child Health Care Hospital, Taian, People's Republic of China; 3 Department of Radiology, Taian Maternity and Child Health Care Hospital, Taian, People's Republic of China Correspondence: Weiwei Zhu, Department of Pediatrics, Jinan Central Hospital, Shandong University, No. 105 Jiefang Road, Jinan, 250013, People's Republic of China, Tel +86-538-6620622, Email Purpose: Early diagnosis of refractory Mycoplasma pneumoniae pneumonia (RMPP) is challenging because of the lack of practical diagnostic imaging tools. Lung ultrasound (LUS) is an emerging tool for diagnosing childhood pneumonia. Hence, we evaluated the role of a nomogram combining LUS findings, clinical features, and laboratory indices in the early prediction of RMPP in children. Patients and Methods: We retrospectively analyzed 225 children with Mycoplasma pneumoniae pneumonia (MPP) admitted to our hospital between Dec 2018 and Aug 2021. Logistic regression analysis incorporated LUS findings and clinical predictors into the nomogram. Ninety patients hospitalized from Sep 2021 to Dec 2021 were used for external validation of the prediction model. Receiver operating characteristics (ROC) and calibration curves were used to evaluate the performance of the nomogram in the early diagnosis of RMPP. Results: Ultimately, Consolidation size /BSA (odds ratio (OR) 1.015, 95% confidence interval (CI) 1.536– 2.446), Pleural Effusion (OR 3.551, 95% CI 1.921– 15.600), LDH (OR 1.044, 95% CI 1.006– 1. 021) and CRP (OR 3.293, 95% CI 1.019– 1.098) were independent risk factors for the development of RMPP. The prediction model was represented visually as a nomogram. The area under the ROC curve for the predictive nomogram was 0.955 (95% CI 0.919– 0.978) in the training cohort and 0.916 (95% CI 0.838– 0.964) in the validation cohort. The calibration curve is close to the diagonal. Conclusion: This is the first-time lung ultrasound was added to the predicted nomogram, which can more comprehensively assess the condition and more accurately predict the occurrence of RMPP early. Therefore, this nomogram can be widely used in the early diagnosis of RMPP, especially in primary care hospitals. Graphical Keywords: predictive model, risk factors, diagnosis, Mycoplasma pneumoniae pneumonia Mycoplasma pneumoniae ( M. pneumoniae ) is common community-acquired pneumonia (CAP) pathogen in school-age children. M. pneumoniae infections occur throughout the year but are more prevalent in summer and autumn, with outbreaks occurring every 2–3 years. 1 In the past ten years, among children with CAP hospitalized in northern China, the incidence of M. pneumoniae pneumonia (MPP) was as high as 37.5%. 2 Conventional wisdom holds that MPP is mild, self-limiting, and not associated with severe complications. 3 The incidence of refractory M. pneumoniae pneumonia (RMPP) has been increasingly reported due to the emergence of macrolide-resistant strains of M. pneumoniae . 3 The diagnostic criteria for RMPP in children remain not standardized. Generally, MPP with persistent high fever and worsening lung imaging findings after treatment with azithromycin or erythromycin for seven days or more is called RMPP. 4 Compared to CMPP, RMPP presents with severe clinical symptoms, longer hospital stays, and is prone to intrapulmonary complications like pleural effusion, pulmonary embolism, and pulmonary infarction, as well as extrapulmonary complications like hemolysis, mucosal skin disease, and central nervous system infections. 1 Macrolide antibiotics are currently effective in treating Mycoplasma pneumoniae pneumonia, 5 but patients with RMPP usually require a longer course of antibiotics and higher doses of glucocorticoids and immunoglobulins. Therefore, it is imperative to identify methods for the early diagnosis of RMPP. Early diagnosis of RMPP is challenging due to the lack of practical imaging diagnostic tools. The mainstream early predictive models combine clinical symptoms, physical examination findings, and laboratory indices. Among predictive models, including clinical symptoms, researchers have found that age, 6 the duration of fever, 7 and pleural effusion 8 are common predictors of RMPP. The risk of RMPP increases with increasing -Abstract Truncated-
pharmacology & pharmacy,infectious diseases